Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Atsuo Takashima
Observed name:
A. Takashima
Institution:
National Cancer Center Hospital
Observed institution:
National Cancer Center Hospital
ORCID:
0000-0002-8456-1248
Observed ORCID:
0000-0002-8456-1248
OpenAlex ID:
A5028718904
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603
2026
·
Yukihide Kanemitsu
, Yasuhiro Shimizu
, et al.
·
Journal of Clinical Oncology
·
27
PDF
737MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic colorectal cancer (mCRC): Final analysis of DESTINY-CRC02, a randomized, phase II trial
2025
·
K. Raghav
, S. Siena
, et al.
·
Annals of Oncology
·
3
10P Phase I study of magrolimab (ONO-7913) and nivolumab (ONO-4538, NIV) in combination with FOLFOX and bevacizumab (Bev) or cetuximab (Cet) as first-line treatment in patients with unresectable advanced or recurrent colorectal cancer (CRC)
2025
·
K. Yamaguchi
, A. Takashima
, et al.
·
Annals of Oncology
·
2
PD-13 Plasma RAS dynamics and efficacy of anti-EGFR rechallenge in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials
2022
·
Y. Kagawa
, D. Kotani
, et al.
·
Annals of Oncology
·
2
Prognostic factors in Japanese patients with advanced gastric cancer using the data from JCOG9912 study.
2011
·
D. Takahari
, A. Takashima
, et al.
·
Journal of Clinical Oncology
·
1
Safety and efficacy of zolbetuximab plus chemotherapy for CLDN18.2-positive gastric cancer: A single-center retrospective study.
2026
·
Shin Kameishi
, Hidekazu Hirano
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
6
Citation count:
35
H-index:
2
I10-index:
1
Year
Topic
Type